Strata Critical Medical reported a 50.3% year-over-year revenue increase to $74.1 million in Q3 2026, driven by growth in its clinical segment and acquisitions. Despite a net loss of $7.6 million, the company improved adjusted EBITDA to $9.6 million and generated $8.6 million in free cash flow. Strata also announced a $20 million share repurchase program to complement its ongoing acquisition strategy. The company reaffirmed its 2026 guidance, expecting revenue between $285-295 million and adjusted EBITDA of $33-35 million.
Strata Critical Medical's third quarter 2026 results provide context for readers interested in health-sector stocks. As of Nov 03, 2026 19:02 WIB, out of 150 priced health-sector US stocks tradable on Pluang, 74 rose and 69 fell. Notable movers include NUVB at USD 4.81 with a 1-day change of +4.79%, ACB at USD 4.40 with +4.27%, and TVTX at USD 47.30 with -3.98%, with a typical hold time on Pluang ranging from 18 to 26 days.
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...
Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...
Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...
Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...
Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...
